Reciprocal interactions between tumor killer dendritic cells and tumor-induced regulatory T lymphocytes
|
University of Arizona / Nicolas Larmonier, PhD |
Young Investigator Grants |
2008 |
Arizona |
Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma |
The Johns Hopkins University School of Medicine / Sama Ahsan, MD |
Young Investigator Grants |
2014 |
Maryland |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
The Role of Prmt1 in Osteosarcoma Initiation and Metastasis |
Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma |
National Cancer Institute / Marielle Yohe, MD/PhD |
Young Investigator Grants |
2016 |
Maryland |
Development of Immunostimulatory DNA as a Novel Therapy in Pediatric Acute Lymphoblastic Leukemia
|
Children’s Hospital of Philadelphia / Alix Seif, MD, MPH |
Young Investigator Grants |
2008 |
Pennsylvania |
The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Ting Tao, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |
PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |